The serious deterioration of the environmental situation and, as a result, the spread of the COVID-19 epidemic indicates the importance of developing the pharmaceutical sector in the interests of people. Along with preventive vaccines, the priority is the creation of effective medicines directed against infectious pathogens that stimulate a person’s own defenses, including the immune system, using the arsenal of autologous pharmacology - the basis of modern medicine from a biomedical point of view